Considering that p-Akt may mediate irradiation-induced VEGF upregulation, it is conceivable that rapamycin, blocking Akt/mTOR pathway, combined with radiotherapy may serve as a novel treatment strategy for cancer through better targeting tumor vasculature [48, 49]. Here, VEGFA is linked to neoplasm.